| Health Technology to Improve Exercise in axSpA (NCT05504616) | University Health Network, Toronto | 2022-07-21 |
| Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis (NCT05881785) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2022-06-13 |
| High-intensity Training in Patients With Spondyloarthritis: a Randomized Controlled Trial (NCT05781763) | Halmstad University | 2022-03-21 |
| Video Coaching of Physical Activity in Axial Spondyloarthritis (NCT03965650) | Assistance Publique - Hôpitaux de Paris | 2022-02-24 |
| Biomedicines and Bacterial Translocation in Spondyloarthritis (NCT05244109) | Centre Hospitalier Universitaire de Besancon | 2022-02-07 |
| REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST) (NCT05164198) | Hanyang University Seoul Hospital | 2022-01-15 |
| Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study (NCT06310057) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2022-01-01 |
| Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis (NCT05115903) | University Health Network, Toronto | 2021-12-01 |
| Physiotherapy of Axial Spondyloarthritis (NCT04679649) | Royal United Hospitals Bath NHS Foundation Trust | 2021-10-06 |
| Exercise Therapy in Patients With Axial Spondyloarthritis (NCT04368494) | Loughborough University | 2021-10-01 |
| Remote Monitoring of Axial Spondyloarthritis (NCT05031767) | Diakonhjemmet Hospital | 2021-09-07 |
| The Turkish Version of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity (NCT05019547) | Acibadem University | 2021-09-01 |
| Reliability of IBP Criteria & Activity Scores in Patients With AxSpA (NCT05327140) | Zagazig University | 2021-08-20 |
| Prevelance of Frailty and Its Associated Factors in Patients With Axial Spondyloarthritis (NCT05010720) | Acibadem University | 2021-08-12 |
| Explore the Associations of Behavioral Factors With Treatment Adherence in Axial Spondyloarthritis Patients Treated With Biotherapy. (NCT04925037) | University Hospital, Clermont-Ferrand | 2021-06-21 |
| Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study (NCT05677542) | Novartis Pharmaceuticals | 2021-06-02 |
| Terbinafine Treatment of Axial Spondyloarthropathy (NCT05119712) | Oregon Health and Science University | 2021-03-09 |
| Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA) (NCT04519866) | Singapore General Hospital | 2021-02-24 |
| The Relationship Between Magnetic Resonance Imaging (MRI) Scores and Sensory Testing in Axial Spondyloarthritis (NCT05021783) | Marmara University | 2021-02-01 |
| The Relationship Between Inflammatory ARTritis and CArdiac DIseAse (NCT05647577) | University Hospital, Gentofte, Copenhagen | 2021-01-01 |
| The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA (NCT04973787) | Universidade Nova de Lisboa | 2020-08-01 |
| Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials (NCT04115098) | The University of Texas Health Science Center, Houston | 2020-06-25 |
| Microbiome and Axial Spondyloarthritis (NCT04713995) | Viome | 2020-06-22 |
| A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) (NCT04163016) | UCB Biopharma SRL | 2020-06-19 |
| A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (NCT04436640) | UCB Biopharma SRL | 2020-06-16 |
| Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe (NCT04397237) | Pitié-Salpêtrière Hospital | 2020-06-10 |
| COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases (NCT04335747) | Salome Kristensen | 2020-04-23 |
| French Validation of Axial Spondyloarthritis Questionnaires (Val-SpA) (NCT04212806) | University Hospital, Grenoble | 2020-01-27 |
| Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases (NCT04200690) | University of Aarhus | 2020-01-14 |
| Investigation of Central Sensitization Frequency and Related Factors in Axial Spondyloarthritis Patients (NCT04485078) | Marmara University | 2019-10-20 |
| Advanced Sensor Based Functional ASsessmenTs in Axial Spondyloarthritis (NCT04489342) | Western Health and Social Care Trust | 2019-07-01 |
| AScalate: Treat-to-target in Axial Spondyloarthritis (NCT03906136) | Novartis Pharmaceuticals | 2019-06-04 |
| PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis (NCT03486613) | Salome Kristensen | 2019-04-24 |
| MRE as a Screening Tool for axSpA in IBD (NCT03817983) | Cambridge University Hospitals NHS Foundation Trust | 2019-03-04 |
| Treat-to-target With Secukinumab in Axial Spondyloarthritis (NCT03639740) | Professor Mikkel Østergaard | 2019-01-15 |
| Rheumatism and Dietetic: RHUMADIET Study (Food Practices and Beliefs) (NCT03770884) | Assistance Publique - Hôpitaux de Paris | 2019-01-08 |
| Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis (NCT03445845) | Centre Hospitalier Universitaire de Saint Etienne | 2018-12-14 |
| Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis (NCT03622658) | Izana Bioscience Ltd. | 2018-09-06 |
| Safety, Tolerability and PK of SHR1314 in axSpA (NCT03704428) | Jiangsu HengRui Medicine Co., Ltd. | 2018-04-19 |
| Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis (NCT03420404) | Singapore General Hospital | 2018-03-05 |
| Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis (NCT03473665) | Columbia University | 2018-03-01 |
| Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission (NCT03425812) | The First Affiliated Hospital of Xiamen University | 2018-02-15 |
| Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation (NCT03270501) | University Ghent | 2017-11-08 |
| A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis (NCT03129100) | Eli Lilly and Company | 2017-05-09 |
| A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA) (NCT02985983) | Kyowa Kirin Co., Ltd. | 2017-03-07 |
| Analysis of DNA Methylation in Spondyloarthritis (NCT03092583) | Centre Hospitalier Universitaire de Besancon | 2017-02-15 |
| Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis) (NCT03043846) | Association de Recherche Clinique en Rhumatologie | 2016-11-30 |
| Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis? (NCT02962479) | Eyal Kedar | 2016-10-01 |
| A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment (NCT02897115) | AbbVie | 2016-09-12 |
| Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site (NCT02771210) | Novartis Pharmaceuticals | 2016-08-30 |
| A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis (NCT02757352) | Eli Lilly and Company | 2016-08-02 |
| Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis (NCT02818478) | Henrik Gudbergsen | 2016-05-01 |
| Add-on Therapy for Axial Spondyloarthritis (NCT02744014) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-04-21 |
| Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients (NCT03582332) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2016-01-02 |
| Incidence of MRI Sacro-Iliac Joint Anomalies in Young Women (NCT02956824) | University Hospital, Montpellier | 2015-11-16 |
| Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS (NCT02552212) | UCB BIOSCIENCES GmbH | 2015-09-01 |
| The Effect of Exercise on Disease Activity and Cardiovascular Risk for Patients With Axial SpondyloArthritis (NCT02356874) | Diakonhjemmet Hospital | 2015-08-01 |
| A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis (NCT02438787) | Janssen Research & Development, LLC | 2015-07-31 |
| Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis (NCT02429882) | Amgen | 2015-05-01 |
| Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases (NCT03214263) | Rigshospitalet, Denmark | 2015-05-01 |
| A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. (NCT02486302) | Pfizer | 2015-03-24 |
| COMorbidities and EDucation in SPondyloArthritis Study (NCT02374749) | Assistance Publique - Hôpitaux de Paris | 2015-03-23 |
| A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (NCT02354105) | UCB Biopharma S.P.R.L. | 2015-01-12 |
| PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients (NCT03039088) | Association de Recherche Clinique en Rhumatologie | 2014-10-02 |
| Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study (NCT02687620) | Izmir Katip Celebi University | 2014-09-01 |
| Exercise Capacity, Cardiovascular Risk Factors and Disease-related Variables in Axial Spondyloarthritis (NCT04706650) | Muğla Sıtkı Koçman University | 2014-05-15 |
| Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs (NCT02089529) | University Hospital of North Norway | 2014-01-01 |
| Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis (NCT01808118) | AbbVie | 2013-04-16 |
| Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis (NCT02011386) | Professor Mikkel Østergaard | 2013-02-01 |
| A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis (NCT01298531) | Pfizer | 2011-05-01 |
| Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) (NCT00844805) | Merck Sharp & Dohme LLC | 2009-09-01 |
| Study of Adalimumab in Patients With Axial Spondyloarthritis (NCT00939003) | AbbVie (prior sponsor, Abbott) | 2009-07-01 |
| Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED) (NCT00726765) | Merck Sharp & Dohme LLC | 2008-06-01 |